- Home
- ACHV vs ICCM Comparison
ACHV vs ICCM Comparison
Compare ACHV & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- ICCM
- Stock Information
- Founded
- ACHV N/A
- ICCM 2006
- Country
- ACHV Canada
- ICCM Israel
- Employees
- ACHV N/A
- ICCM N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ICCM
- Sector
- ACHV Health Care
- ICCM
- Exchange
- ACHV Nasdaq
- ICCM Nasdaq
- Market Cap
- ACHV 72.5M
- ICCM 70.1M
- IPO Year
- ACHV N/A
- ICCM N/A
- Fundamental
- Price
- ACHV $2.35
- ICCM $1.03
- Analyst Decision
- ACHV Strong Buy
- ICCM Strong Buy
- Analyst Count
- ACHV 3
- ICCM 1
- Target Price
- ACHV $14.33
- ICCM $2.50
- AVG Volume (30 Days)
- ACHV 178.2K
- ICCM 199.2K
- Earning Date
- ACHV 05-13-2025
- ICCM 05-27-2025
- Dividend Yield
- ACHV N/A
- ICCM N/A
- EPS Growth
- ACHV N/A
- ICCM N/A
- EPS
- ACHV N/A
- ICCM N/A
- Revenue
- ACHV N/A
- ICCM $3,291,000.00
- Revenue This Year
- ACHV N/A
- ICCM $97.02
- Revenue Next Year
- ACHV N/A
- ICCM $212.86
- P/E Ratio
- ACHV N/A
- ICCM N/A
- Revenue Growth
- ACHV N/A
- ICCM 1.92
- 52 Week Low
- ACHV $1.84
- ICCM $0.48
- 52 Week High
- ACHV $5.59
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- ACHV 46.09
- ICCM 37.29
- Support Level
- ACHV $2.32
- ICCM $1.00
- Resistance Level
- ACHV $2.69
- ICCM $1.10
- Average True Range (ATR)
- ACHV 0.18
- ICCM 0.08
- MACD
- ACHV 0.02
- ICCM -0.01
- Stochastic Oscillator
- ACHV 17.07
- ICCM 8.82
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.